Raju Gottumukkala, PhD
About Raju Gottumukkala, PhD
Raju Gottumukkala, PhD, is a Senior QC Specialist at Kite Pharma with extensive experience in clinical immunology and regulatory review in the diagnostic industry. He has held various roles in prestigious organizations, including the FDA and NIH, and possesses expertise in molecular biology and autoimmune diseases.
Current Role at Kite Pharma
Raju Gottumukkala serves as a Senior QC Specialist at Kite Pharma, a position he has held since 2022. In this role, he is responsible for ensuring the quality control processes meet the necessary standards for the company's products. His expertise in analytical development and quality control contributes to the overall efficacy and safety of Kite Pharma's offerings.
Previous Experience in Clinical Immunology
Prior to his current role, Raju Gottumukkala worked at Novavax as a Scientist in Clinical Immunology from 2014 to 2017. During his tenure in Gaithersburg, MD, he focused on clinical translational studies related to heart failure, myocardial infarction, and diabetes. His work involved the development and validation of diagnostic assays, enhancing the understanding of these conditions.
Regulatory Experience at FDA
Raju Gottumukkala has significant experience in regulatory affairs, having worked at the FDA as a Senior Staff Fellow for five months in 2021. He also served as an In-Vitro Diagnostic Subject Matter Expert from 2020 to 2021. His involvement included the regulatory review of diagnostic industry applications, contributing to the oversight of medical products.
Educational Background and Expertise
Raju Gottumukkala holds a Doctor of Philosophy (PhD) in Autoimmune/Inflammatory diseases from The University of Sheffield, where he studied from 2001 to 2005. He also obtained a Master’s Degree in Medical Molecular Genetics from the University of Aberdeen and a Bachelor’s Degree in Fisheries Science from Acharya N.G. Ranga Agricultural University. His educational background supports his expertise in molecular biology and immunoassays.
Research and Development Contributions
Throughout his career, Raju Gottumukkala has contributed to the development and validation of novel biomarker and diagnostic assays for autoimmune diseases, including Vitiligo and Type 1 Diabetes. He has experience in troubleshooting and transferring analytical assays for biologics, including monoclonal antibodies and vaccine candidates for infectious diseases such as HIV and Ebola.